Front Range Biosciences Raises $10 Million in Series A Financing

BOULDER, Colo.Oct. 4, 2018 /PRNewswire/ — Front Range Biosciences®, a leading agricultural biotech company specializing in tissue culture propagation of high value crops, today announced that it has completed a $10 million Series A round of financing with participation from Phyto Partners, WelCan Capital, Salveo Capital, Cornerstone Opportunity Partners, Sand Hill Angels, Harvard Business School Alumni Angels of New York, New York Angels, Altitude Investment Management, and other new and returning investors. This marks the largest fundraising by a U.S. cannabis biotech company to date.

“This financing will help us accelerate our Clean Stock® program in ColoradoCalifornia, and Canada, in addition to aggressively pursuing IP development and resourcing our varietal development program for hemp and cannabis,” said Dr. Jonathan Vaught, CEO and co-founder of FRB.

Read the full press release here. 


Leave a reply